SEK 61.7
(2.32%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 21.61 Billion SEK | 8.77% |
2022 | 19.87 Billion SEK | 14.3% |
2021 | 17.38 Billion SEK | 4.44% |
2020 | 16.64 Billion SEK | -17.98% |
2019 | 20.29 Billion SEK | 24.64% |
2018 | 16.28 Billion SEK | 12.46% |
2017 | 14.48 Billion SEK | 2.16% |
2016 | 14.17 Billion SEK | 8.8% |
2015 | 13.02 Billion SEK | -10.39% |
2014 | 14.53 Billion SEK | 24.96% |
2013 | 11.63 Billion SEK | 8.26% |
2012 | 10.74 Billion SEK | 5.11% |
2011 | 10.22 Billion SEK | 99.36% |
2010 | 5.12 Billion SEK | -2.69% |
2009 | 5.27 Billion SEK | -2.32% |
2008 | 5.39 Billion SEK | 19.91% |
2007 | 4.5 Billion SEK | 28.83% |
2006 | 3.49 Billion SEK | 2.25% |
2005 | 3.41 Billion SEK | 21.78% |
2004 | 2.8 Billion SEK | 68.67% |
2003 | 1.66 Billion SEK | 9.62% |
2002 | 1.51 Billion SEK | 20.59% |
2001 | 1.25 Billion SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 20.7 Billion SEK | -4.21% |
2023 FY | 21.61 Billion SEK | 8.77% |
2023 Q3 | 20.47 Billion SEK | -3.61% |
2023 Q4 | 21.61 Billion SEK | 5.57% |
2023 Q1 | 20.6 Billion SEK | 3.66% |
2023 Q2 | 21.24 Billion SEK | 3.12% |
2022 Q2 | 18.09 Billion SEK | 4.95% |
2022 Q3 | 18.34 Billion SEK | 1.38% |
2022 FY | 19.87 Billion SEK | 14.3% |
2022 Q1 | 17.24 Billion SEK | -0.85% |
2022 Q4 | 19.87 Billion SEK | 8.36% |
2021 Q3 | 18.63 Billion SEK | 18.65% |
2021 Q4 | 17.38 Billion SEK | -6.67% |
2021 FY | 17.38 Billion SEK | 4.44% |
2021 Q2 | 15.7 Billion SEK | -0.8% |
2021 Q1 | 15.82 Billion SEK | -4.93% |
2020 Q4 | 16.64 Billion SEK | -3.5% |
2020 Q2 | 17.49 Billion SEK | -7.75% |
2020 FY | 16.64 Billion SEK | -17.98% |
2020 Q1 | 18.96 Billion SEK | -6.55% |
2020 Q3 | 17.25 Billion SEK | -1.4% |
2019 Q1 | 17 Billion SEK | 4.43% |
2019 FY | 20.29 Billion SEK | 24.64% |
2019 Q2 | 17.34 Billion SEK | 1.97% |
2019 Q3 | 17.03 Billion SEK | -1.79% |
2019 Q4 | 20.29 Billion SEK | 19.18% |
2018 Q4 | 16.28 Billion SEK | 5.53% |
2018 FY | 16.28 Billion SEK | 12.46% |
2018 Q3 | 15.43 Billion SEK | -1.56% |
2018 Q2 | 15.67 Billion SEK | 3.96% |
2018 Q1 | 15.07 Billion SEK | 4.12% |
2017 Q1 | 13.14 Billion SEK | -7.25% |
2017 Q4 | 14.48 Billion SEK | 6.66% |
2017 FY | 14.48 Billion SEK | 2.16% |
2017 Q3 | 13.57 Billion SEK | 1.18% |
2017 Q2 | 13.41 Billion SEK | 2.05% |
2016 Q4 | 14.17 Billion SEK | 6.85% |
2016 Q2 | 13.48 Billion SEK | 3.98% |
2016 Q3 | 13.26 Billion SEK | -1.64% |
2016 FY | 14.17 Billion SEK | 8.8% |
2016 Q1 | 12.97 Billion SEK | -0.45% |
2015 Q1 | 14.48 Billion SEK | -0.41% |
2015 Q3 | 13.14 Billion SEK | 0.11% |
2015 FY | 13.02 Billion SEK | -10.39% |
2015 Q2 | 13.13 Billion SEK | -9.31% |
2015 Q4 | 13.02 Billion SEK | -0.89% |
2014 Q1 | 11.18 Billion SEK | -3.91% |
2014 Q4 | 14.53 Billion SEK | 13.81% |
2014 Q3 | 12.77 Billion SEK | 9.81% |
2014 FY | 14.53 Billion SEK | 24.96% |
2014 Q2 | 11.63 Billion SEK | 4.06% |
2013 Q1 | 10.2 Billion SEK | -5.03% |
2013 Q3 | 10.57 Billion SEK | 2.08% |
2013 Q2 | 10.36 Billion SEK | 1.52% |
2013 Q4 | 11.63 Billion SEK | 10.01% |
2013 FY | 11.63 Billion SEK | 8.26% |
2012 FY | 10.74 Billion SEK | 5.11% |
2012 Q4 | 10.74 Billion SEK | 7.96% |
2012 Q3 | 9.95 Billion SEK | -0.1% |
2012 Q2 | 9.96 Billion SEK | 1.31% |
2012 Q1 | 9.83 Billion SEK | -3.8% |
2011 Q1 | 6.13 Billion SEK | 19.54% |
2011 Q4 | 10.22 Billion SEK | 15.02% |
2011 Q3 | 8.89 Billion SEK | 9.32% |
2011 FY | 10.22 Billion SEK | 99.36% |
2011 Q2 | 8.13 Billion SEK | 32.64% |
2010 Q1 | 5.08 Billion SEK | -3.53% |
2010 FY | 5.12 Billion SEK | -2.69% |
2010 Q3 | 5.23 Billion SEK | 6.08% |
2010 Q4 | 5.12 Billion SEK | -2.02% |
2010 Q2 | 4.93 Billion SEK | -2.95% |
2009 Q4 | 5.27 Billion SEK | 0.0% |
2009 FY | 5.27 Billion SEK | -2.32% |
2008 FY | 5.39 Billion SEK | 19.91% |
2007 FY | 4.5 Billion SEK | 28.83% |
2006 FY | 3.49 Billion SEK | 2.25% |
2005 FY | 3.41 Billion SEK | 21.78% |
2004 FY | 2.8 Billion SEK | 68.67% |
2003 FY | 1.66 Billion SEK | 9.62% |
2002 FY | 1.51 Billion SEK | 20.59% |
2001 FY | 1.25 Billion SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AddLife AB (publ) | 7.78 Billion SEK | -177.701% |
Biotage AB (publ) | 1.27 Billion SEK | -1596.939% |
Bonesupport Holding AB (publ) | 143.63 Million SEK | -14950.926% |
Doxa AB (publ) | 280.8 Million SEK | -7599.074% |
iZafe Group AB (publ) | 9.26 Million SEK | -233341.313% |
Ortivus AB (publ) | 55.4 Million SEK | -38922.761% |
Ortivus AB (publ) | 55.4 Million SEK | -38922.761% |
Q-linea AB (publ) | 42.34 Million SEK | -50960.463% |
S2Medical AB (publ) | 19.74 Million SEK | -109366.334% |
Synsam AB (publ) | 5.52 Billion SEK | -291.578% |